1. Home
  2. Conferences
  3. Regulatory Summit North America 2025
  4. programme

Agenda

  1. Coffee and registration

  2. Welcome and introduction

    Fourat Muziel Fourat Muziel
    Regulatory & Compliance Analyst, Enhesa Product
  3. Session 1: Regulatory landscape & policy updates

  4. PFAS policy, regulatory, and stewardship developments in the U.S.

    • the Administration’s evolving PFAS policy;
    • Federal regulatory initiatives;
    • State regulatory initiatives; and
    • stewardship trends.
    Lynn L. Bergeson Lynn L. Bergeson
    Managing Partner of Bergeson & Campbell, P.C. (B&C®) and President of The Acta Group, L.L.C. (Acta®), Bergeson & Campbell, USA

  5. PFAS regulation in the U.S. States and Canada

    • all PFAS are not the same: overview of sub-groups of PFAS;
    • the unique combination of properties that make fluoropolymers indispensable to multiple industries;
    • an overview of PFAS regulation in the U.S. states with select case studies; and
    • Canada’s approach to PFAS assessment and regulation.
    Jay West Jay West
    Executive Director of ACC’s Performance Fluoropolymer Partnership, American Chemistry Council (ACC)

  6. Using TSCA to turn off the PFAS tap: Opportunities and benefits

    Maria Doa Maria Doa
    Senior Director, Chemical Policy, Environmental Defence Fund

  7. Q&A session

  8. Refreshment break

  9. Session 2: Global overview

  10. Maine State PFAS updates

    Kerri Malinowski Farris Kerri Malinowski Farris
    Program Manager for Maine’s Safer Chemicals Program, Maine Department of Environmental Protection

  11. PFAS restrictions in LatAM

    Nidia Mariana Calvo Mendez Nidia Mariana Calvo Mendez
    Americas Managing Analyst, Enhesa Product Intelligence

  12. EU PFAS updates

    • where does the proposed PFAS restriction stand?; and
    • PFAS litigation cases in the EU — something quite new. 
    Herb Estreicher Herb Estreicher
    Partner, Keller and Heckman LLP, United States

  13. Q&A session

  14. Lunch and networking

  15. Welcome back

    Fourat Muziel Fourat Muziel
    Regulatory & Compliance Analyst, Enhesa Product
  16. Session 3: Compliance & industry impact

  17. Toxics Release Inventory (TRI) updates

  18. US PFAS and the EPA strategic roadmap: Progress and challenges

  19. PFAS litigation: What it is and why it matters

    • why you should care about PFAS litigation;
    • PFAS-related causes of action;
    • challenges presented by PFAS litigation; and
    • key takeaways and recommendations.
    Michael Boucher Michael Boucher
    Partner, Steptoe

  20. Q&A session

  21. Refreshment break

  22. Session 4: Science, testing & innovation

  23. How PFAS analytical methods shape regulation and risk

    Elizabeth Denly Elizabeth Denly
    PFAS Initiative Leader & Chemistry Director, TRC

  24. Strategies retailers are using to reduce PFAS with examples

    Mike Schade Mike Schade
    Senior Director of Programs and Strategy, Toxic-Free Future, United States

  25. PFAS-Free alternatives & sustainable innovation / avoiding regrettable substitution

    Baskut Tuncak Baskut Tuncak
    Director, Toxics Use Reduction Institute, TURI

  26. Q&A session

  27. Close of conference

View previous day

/ next day
Back to top